- Version
- Download 0
- File Size 4.60 MB
- File Count 1
- Create Date October 27, 2024
- Last Updated October 27, 2024
Zhejiang Hisun Pharmaceutical Q3 2024 valuation
Zhejiang Hisun Pharmaceutical Co., Ltd. is a long-established player in the Chinese pharmaceutical industry with a substantial global footprint, particularly in APIs and finished dosage products. The company's ongoing investments in biopharmaceuticals and strategic partnerships support its transition into high-value therapeutic areas, positioning it for future growth in a dynamic healthcare market.
